This item is authorised by the following title:
sch 2 (item 1) of the Therapeutic Goods (Therapeutic Goods Advertising Code) Amendment (2022 Measures No. 1) Instrument 2022
When documents are presented to the Australian Parliament for scrutiny, they are said to have been tabled.